Plasma EBV microRNAs in paediatric renal transplant recipients

Jaythoon Hassan1, Jonathan Dean2, Cillian F De Gascun2

  • 1National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, Ireland. jaythoon.hassan@ucd.ie.

Journal of Nephrology
|November 30, 2017
PubMed
Abstract

Insights

Epstein-Barr virus (EBV) microRNAs (miRNAs) were profiled in pediatric kidney transplant patients. EBV-miR-BART2-5p may sustain high viral loads in chronic high EBV patients, potentially aiding in post-transplant lymphoproliferative disease development.

Area of Science:

  • Virology
  • Immunology
  • Transplantation

Background:

  • Epstein-Barr virus (EBV) was the first human virus found to express microRNAs (miRNAs).
  • 44 mature miRNAs are encoded in the EBV genome.
  • EBV miRNA profiles in pediatric renal transplant recipients have not been previously studied.

Purpose of the Study:

  • To investigate circulating EBV miRNA profiles as potential biomarkers in pediatric renal transplant patients.
  • To explore the role of EBV miRNAs in different EBV infection states post-transplantation.

Main Methods:

  • Examined 42 EBV miRNAs from BART and BHRF open reading frames.
  • Analyzed samples from renal transplant recipients with resolved EBV infection (REI) or chronic high viral loads (CHL).
  • Included non-transplant patients with acute infectious mononucleosis (IM) as controls.

Main Results:

  • Plasma EBV-miR-BART2-5p was elevated in IM and CHL patients compared to REI patients.
  • A trend suggested a correlation between EBV miRNA levels and EBV viral load.
  • Specific EBV-miRs were detected only in IM and CHL patients, while lytic EBV-miRs were found only in IM patients.
  • One CHL patient who developed post-transplant lymphoproliferative disease (PTLD) showed significantly higher EBV-miR-BART2-5p levels.

Conclusions:

  • EBV-miR-BART2-5p may contribute to maintaining high EBV viral loads in CHL pediatric kidney transplant recipients.
  • This miRNA targets MICB to evade NK cell recognition, potentially playing a role in PTLD development.
  • Circulating EBV miRNAs show promise as biomarkers in pediatric renal transplant recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
533
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
418
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
356
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
477